Amphotericin B cholesteryl sulfate contraindications: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Amphotericin B cholesteryl sulfate}} | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==Contraindications== | ==Contraindications== | ||
AMPHOTEC should not be administered to patients who have documented hypersensitivity to any of its components, unless, in the opinion of the physician, the advantages of using AMPHOTEC outweigh the risks of hypersensitivity.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMPHOTEC (AMPHOTERICIN B) INJECTION, LIPID COMPLEX [INTERMUNE, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b8ea543-1de8-472f-9666-34f99ca2f183 | publisher = | date = | accessdate = }}</ref> | AMPHOTEC should not be administered to patients who have '''documented [[hypersensitivity]]''' to any of its components, unless, in the opinion of the physician, the advantages of using AMPHOTEC outweigh the risks of hypersensitivity.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMPHOTEC (AMPHOTERICIN B) INJECTION, LIPID COMPLEX [INTERMUNE, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b8ea543-1de8-472f-9666-34f99ca2f183 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 07:22, 10 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Contraindications
AMPHOTEC should not be administered to patients who have documented hypersensitivity to any of its components, unless, in the opinion of the physician, the advantages of using AMPHOTEC outweigh the risks of hypersensitivity.[1]
References
Adapted from the FDA Package Insert.